TERM ID="NYU_TERM_1" STRING="AD" FREQUENCY=1 START=391 END=393 LEMMA="ATOPIC DERMATITIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_2" STRING="AR-GG27" FREQUENCY=4 START=660 END=667 LEMMA="AR-GG27" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_3" STRING="AR-GG27" FREQUENCY=4 START=2200 END=2207 LEMMA="AR-GG27" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_4" STRING="AR-GG27" FREQUENCY=4 START=2331 END=2338 LEMMA="AR-GG27" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_5" STRING="AR-GG27" FREQUENCY=4 START=2494 END=2501 LEMMA="AR-GG27" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_6" STRING="Emollients" FREQUENCY=1 START=1251 END=1261 LEMMA="EMOLLIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Global Assessment" FREQUENCY=1 START=1682 END=1699 LEMMA="GLOBAL ASSESSMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Hanifin" FREQUENCY=1 START=419 END=426 LEMMA="HANIFIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="IGA" FREQUENCY=1 START=1701 END=1704 LEMMA="INVESTIGATOR GLOBAL ASSESSMENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_10" STRING="Investigator" FREQUENCY=1 START=1669 END=1681 LEMMA="INVESTIGATOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="Investigator Global Assessment" FREQUENCY=2 START=1669 END=1699 LEMMA="INVESTIGATOR GLOBAL ASSESSMENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_12" STRING="Investigator Global Assessment" FREQUENCY=2 START=1669 END=1699 LEMMA="INVESTIGATOR GLOBAL ASSESSMENT" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_13" STRING="PA" FREQUENCY=1 START=249 END=251 LEMMA="PHYSICAL ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="Pityriasis alba" FREQUENCY=1 START=232 END=247 LEMMA="PITYRIASIS ALBA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_15" STRING="Rajka criteria" FREQUENCY=1 START=431 END=445 LEMMA="RAJKA CRITERION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="TIMs" FREQUENCY=1 START=1109 END=1113 LEMMA="TIM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="VAS" FREQUENCY=1 START=2032 END=2035 LEMMA="VISUAL ANALOGUE SCALE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_18" STRING="Visual Analogue Scale" FREQUENCY=2 START=2009 END=2030 LEMMA="VISUAL ANALOGUE SCALE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_19" STRING="Visual Analogue Scale" FREQUENCY=2 START=2009 END=2030 LEMMA="VISUAL ANALOGUE SCALE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_20" STRING="Xerosis" FREQUENCY=1 START=1001 END=1008 LEMMA="XEROSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="atopic dermatitis" FREQUENCY=2 START=372 END=389 LEMMA="ATOPIC DERMATITIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="atopic dermatitis" FREQUENCY=2 START=372 END=389 LEMMA="ATOPIC DERMATITIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_23" STRING="clinical signs" FREQUENCY=1 START=1811 END=1825 LEMMA="CLINICAL SIGN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="clinical trial Pityriasis alba" FREQUENCY=1 START=217 END=247 LEMMA="CLINICAL TRIAL PITYRIASIS ALBA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="containing AR-GG27" FREQUENCY=1 START=37 END=55 LEMMA="CONTAINING AR-GG27" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="dermatological skin conditions" FREQUENCY=1 START=2582 END=2612 LEMMA="DERMATOLOGICAL SKIN CONDITION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="diabetes mellitus" FREQUENCY=1 START=1485 END=1502 LEMMA="DIABETES MELLITUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="double-blind" FREQUENCY=2 START=184 END=196 LEMMA="DOUBLE-BLIND" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_29" STRING="double-blind" FREQUENCY=2 START=805 END=817 LEMMA="DOUBLE-BLIND" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_30" STRING="endpoint" FREQUENCY=1 START=1752 END=1760 LEMMA="ENDPOINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="erythema" FREQUENCY=1 START=1827 END=1835 LEMMA="ERYTHEMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="excoriation desquamation" FREQUENCY=1 START=1837 END=1861 LEMMA="EXCORIATION DESQUAMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="fungal overinfection" FREQUENCY=1 START=1447 END=1467 LEMMA="FUNGAL OVERINFECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="hypopigmented patches" FREQUENCY=1 START=303 END=324 LEMMA="HYPOPIGMENTED PATCH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="inflammation" FREQUENCY=1 START=2630 END=2642 LEMMA="INFLAMMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="manifestation" FREQUENCY=1 START=524 END=537 LEMMA="MANIFESTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="mild/moderate childhood atopic dermatitis" FREQUENCY=1 START=107 END=148 LEMMA="MILD/MODERATE CHILDHOOD ATOPIC DERMATITIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="phototherapy" FREQUENCY=1 START=1182 END=1194 LEMMA="PHOTOTHERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="pityriasis alba" FREQUENCY=1 START=165 END=180 LEMMA="PITYRIASIS ALBA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_40" STRING="primary endpoint" FREQUENCY=1 START=1604 END=1620 LEMMA="PRIMARY ENDPOINT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="pruritus severity" FREQUENCY=1 START=1911 END=1928 LEMMA="PRURITUS SEVERITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="sorbityl furfural palmitate" FREQUENCY=2 START=58 END=85 LEMMA="SORBITYL FURFURAL PALMITATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_43" STRING="sorbityl furfural palmitate" FREQUENCY=2 START=670 END=697 LEMMA="SORBITYL FURFURAL PALMITATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_44" STRING="study population" FREQUENCY=1 START=2393 END=2409 LEMMA="STUDY POPULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="subjective five-point scale" FREQUENCY=1 START=1871 END=1898 LEMMA="SUBJECTIVE FIVE-POINT SCALE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="symptom" FREQUENCY=1 START=2445 END=2452 LEMMA="SYMPTOM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="systemic diseases" FREQUENCY=1 START=1511 END=1528 LEMMA="SYSTEMIC DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="systemic therapy" FREQUENCY=1 START=1161 END=1177 LEMMA="SYSTEMIC THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="systemic treatments" FREQUENCY=1 START=1339 END=1358 LEMMA="SYSTEMIC TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="tissue oxidative stress" FREQUENCY=1 START=2647 END=2670 LEMMA="TISSUE OXIDATIVE STRESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="tolerability" FREQUENCY=3 START=13 END=25 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_52" STRING="tolerability" FREQUENCY=3 START=644 END=656 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_53" STRING="tolerability" FREQUENCY=3 START=2566 END=2578 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_54" STRING="tolerability of AR-GG27" FREQUENCY=1 START=644 END=667 LEMMA="AR-GG27 TOLERABILITY" LEMMA_FREQUENCY=1 HEAD_TERM="tolerability" HEAD_LEMMA="TOLERABILITY"
TERM ID="NYU_TERM_55" STRING="topical calcineurin inhibitors" FREQUENCY=1 START=1077 END=1107 LEMMA="TOPICAL CALCINEURIN INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="topical steroids" FREQUENCY=1 START=1057 END=1073 LEMMA="TOPICAL STEROID" LEMMA_FREQUENCY=1
